MolDX: Phenotypic Biomarker Detection from Circulating Tumor Cells; Billing and Coding: MolDX: Phenotypic Biomarker Detection from Circulating Tumor Cells - Effective July 4, 2021

This Local Coverage Determination (LCD) has completed the Open Public Meeting comment period and is now finalized under contractor numbers: 02101 (AK), 03101 (AZ), 02201 (ID), 03201 (MT), 03301 (ND), 02301 (OR), 03401 (SD), 03501 (UT), 02401 (WA), and 03601 (WY).

Medicare Coverage Database Number LCD Title
L38645 MolDX: Phenotypic Biomarker Detection from Circulating Tumor Cells

 

Medicare Coverage Database Number Billing and Coding Article
A58185 Billing and Coding: MolDX: Phenotypic Biomarker Detection from Circulating Tumor Cells

 

Effective Date: July 4, 2021
Summary: Limited coverage policy for assays that detect biomarkers from circulating tumor cells (CTCs)

Visit the Future LCDs webpage to access this LCD.

 

            Last Updated Wed, 26 May 2021 20:09:03 +0000